Plain-English translation of NCT06528964 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →Researchers are studying whether abnormal proteins found in the brains of people with neurodegenerative diseases—such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS)—can also be detected in skin samples. If they can, a simple skin biopsy might one day become a new way to help diagnose or understand these serious brain diseases earlier and more easily than current methods.
Diagnosing neurodegenerative diseases can be difficult and often requires invasive brain imaging or testing. Researchers hope that if abnormal proteins can be reliably found in skin samples, it could lead to a simpler, less invasive way to detect and understand these diseases, potentially helping patients get diagnosed and treated sooner.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would visit the hospital's neurology department once to have a small skin biopsy taken—a simple procedure where a tiny sample of skin is removed (usually from the forearm or leg) using local numbing medicine. The sample is then examined under a microscope to look for the same abnormal proteins seen in neurodegenerative diseases. The entire process is quick and non-invasive, and you would not need to return for follow-up visits related to the biopsy itself.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Mexico